Mouse teratocarcinoma cells from the OTT6050 ascites tumor were established in tissue culture and selected for 5-bromodeoxyuridine (BrdUrd) resistance. The embryonal carcinoma cells grew without a feeder layer, remained deficient for thymidine kinase (EC 2.7.1.75), and differentiated like the original tumor into various tissues after subcutaneous injection into 129 mice. We fused the BrdUrdresistant mouse teratocarcinoma cells with HT10806T human
diploid fibrosarcoma cells deficient in hypoxanthine phosphoribosyltransferase (EC 2.4.2.8) and selected for hybrid cells in hypoxanthine/aminopterin/thymidine medium. The resulting hybrid cells segregated human chromosomes quickly and retained one to three human chromosomes including chromosome 17 that carries the human genes for thymidine kinase and galactokinase (EC 2.7.1.6). Single hybrid cells from five independent clones containing human chromosome 17 were injected into mouse blastocysts bearing several genetic markers that affect the coat color phenotype and strain-specific enzyme variants in order to detect tissue differentiation derived from the injected cells. After the injection of single hybrid cells into a total of 103 experimental blastocysts that had been surgically transferred to pseudopregnant foster mothers, 49 mice were born and 2 of them clearly revealed coat mosaicism. In 2 of 17 mice thus far analyzed, the injected hybrid cells proved to be capable of participating substantially in development of seven different organs. However, human gene products have not yet been detected unequivocally in those tissues and weak human-specific galactokinase activity could be recovered only from two mosaic tissues.
Our results demonstrate that, after in vitro culture and selection, at least some of the human-mouse hybrid cells still retain their in vivo potential to differentiate and become functionally integrated in the living organism. It now seems feasible to cycle mouse teratocarcinoma cells carrying human genetic material through mice via blastocyst injection to study human gene expression during differentiation.
Mouse teratocarcinomas are tumors that either develop spontaneously in the gonads or can be produced experimentally by grafting early embryos into the testis of syngeneic hosts (1, 2) . They contain various aberrantly differentiated and chaotically organized tissues that include derivatives of all three germ layers. Usually these tumors are benign and nontransplantable, and they are then referred to as "teratomas." Occasionally, however, in addition they contain embryonal carcinoma cells, the stem cell population of highly malignant teratocarcinomas (3) . Those stem cells scattered throughout the solid tumor or propagated as "embryoid bodies" in an ascites form continue to divide and proliferate, and sometimes even invade and metastasize, thereby retaining the malignant properties of transplantable tumors.
Recently, it was shown that, after microinjection into mouse blastocysts, embryonal carcinoma cells participated in normal development (4) and clonally contributed to virtually all major The costs of publication of this article were defrayed in part by the payment of page charges. This article must therefore be hereby marked "advertisement" in accordance with 18 U. S. C. §1734 solely to indicate this fact. adult tissues (5, 6) . It therefore appears as if the initially malignant teratocarcinoma cells always grown in vivo remain developmentally totipotent and are able to express their genetic repertoire normally after being exposed to the appropriate embryonic environment. In a similar bioassay, in vitro cultured cells derived from other teratocarcinomas were also capable of contributing to several somatic tissues, although most of the chimeric mice additionally developed tumors in various anatomical sites (7) . Furthermore, it was recently found that, even after in vitro selection for a particular genetic defect, the mutant teratocarcinoma cells still retained their in vivo potential to a remarkable extent (8) . It thus seemed logical to find out whether foreign genetic material can be introduced into embryonal carcinoma cells via somatic cell hybridization in order to reveal its developmental and biochemical phenotype in the living organism via blastocyst injection.
In the experiments reported here, mouse teratocarcinoma cells of the OTT6050 tumor origin first were selected in vitro for thymidine kinase (10) . Colonies that appeared within 2-3 weeks were picked by using glass rings and EDTA/trypsin and grown in T25 Falcon flasks in RPMI/HAT medium. Cells derived from different colonies were then cloned by placing single cells in microwells of Limbro plates. These clones were subsequently transferred to Falcon flasks and maintained in culture under selective conditions. Karyologic Analysis. The parental and hybrid clones were stained for chromosome banding by a trypsin/Giemsa staining technique (14) . At least 15 different metaphases of cells from each clone were studied in order to identify individual mouse and human chromosomes by their characteristic banding patterns.
Collection of Embryos and Cells. Inbred C57BL/6J (BL6) and SJL/J females were selected in proestrus (15) and mated with males of the same strains. The next morning, the females with vaginal plugs were separated and then killed on postcoitus day3. Embryos at the early morula stage were flushed from the oviducts and cultured in modified Whitten's medium (16) until the blastocyst stage. After thisin vitro incubation, a group of five well-expanded BL6 blastocysts were transferred into a small drop of Ca2+-free medium (Dulbecco's modification of Eagle's minimal essential medium, DMEM) supplemented with bovine serum albumin (10 mg/ml) and 10mM N-2-hydroxyethylpiperazine-N'-2-ethanesulfonic acid (Hepes) on a special microscope slide. The medium had previously been covered with halofluorocarbon oil (Voltalef 10 S).
In order to collect hybrid cells, the original medium in a culture flask was replaced by Ca2+-free medium. After 20-min incubation at 370, the cells were gently flushed from the bottom of the flask and transferred to a siliconized depression slide and stored under paraffin oil. For each experimental series, about 30 cells were selected and placed near the recipient blastocysts for subsequent injection.
Micromanipulation. The injection pipets were prepared from 1.2-mm (outside diameter) Pyrex tubing (Corning Glass) that had been pulled to a15-,um tip and then sharpened on a special grinding wheel and a DeFonbrune microforge. After thorough cleaning in sulfuric acid, the pipets were siliconized (Siliclad) and stored under sterile conditions. For microinjection, the capillary was connected to a syringe (Hamilton) containing paraffin oil, and the distal part was filled with halofluorocarbon oil (Voltalef 3S). The holding pipet, with a blunt (60,um) tip, was connected to another syringe system and its distal half was filled with Ca2+-free medium. Both glass capillaries could be controlled by Leitz micromanipulators equipped with a Zeiss inverted UPL microscope. The injection pipet, into which a single cell had been sucked together with a small amount of medium, was slowly pushed through the zona pellucida and trophoblast into the inner cell mass of blastocyst, properly attached to the holding capillary.
After injection, the pipet had to be withdrawn very gently in order to prevent the implanted cell from being misplaced in the blastocoel of the recipient. All injected blastocysts were incubated in Whitten's medium for about 2 hr at 370 before transfer to foster females.
Seven experimental BL6 and three control SJL blastocysts were surgically transplanted to the uterus of a pseudopregnant C57BL/lOWt X SJL/Wt (B1OSJLF1) mother at postcoitus day 3 or 4. These females had been selected in proestrus and mated to sterile (vasectomized) B1OSJLF1 males.
Analyses of Tissue Genotypes. Strain-specific allelic variants of mouse glucosephosphate isomerase (GPI; D-glucose-6-phosphate ketolisomerase, EC 5.3.1.9) (Cpl-1 locus on chromosome 7) in blood cell lysates and tissue homogenates were determined on cellulose acetate plates (17) . In addition, in order to exclude any contamination that might have occurred after spontaneous aggregation of BL6 blastocysts with cells from the SJL control blastocysts in utero, heart, muscle, and kidney tissue of chimeric mice A and B were studied for the expression of mouse phosphoglucomutase 1 (Pgm-1, EC 2.7.5.1) and isocitrate dehydrogenase (Id-l, EC 1.1.1.42) by starch gel electrophoresis (18) .
Electrophoretically different forms of mouse and human GLK (Gik locus on chromosomes 11 and 17, respectively) in tissue homogenates were assayed on starch gels by fluorescent staining techniques (19) . RESULTS In previous studies, mouse teratocarcinoma cells of 0TT6050 tumor origin were established in tissue culture and selected for BrdUrd resistance. After subeutaneous transplantation to syngeneic 129 mice, the mutant teratocarcinoma cells still expressed their malignant as well as pluripotent properties (Fig.  1) , similar to the original ascites tumor.
We found that, after microinjection into mouse blastocysts, some of these TK-teratocarcinoma cells became integrated during normal development and contributed substantially to several internal organs-e.g., liver, lung, heart, brain, and skeletal muscle. However, the frequency of tissue mosaicism (about 10%) in adult chimeric mice was reduced compared with the rate of integration (about 25%o) obtained from embryonal carcinoma cells of the original tumor (cf. 6; unpublished data). Nevertheless, these results provided good evidence that teratocarcinoma cells selected in vitro for TK deficiency were still able to differentiate in vivo into various different tissues and should therefore be useful carriers for introducing and analyzing foreign genetic material in the living organism.
TK-deficient teratocarcinoma cells were then hybridized to HT1080-6TG human fibrosarcoma cells deficient in HPRT and Two of the experimental progeny clearly showed coat mosaicism. Chimeric mouse A, a male originating from a clone 3 cell-injected blastocyst and autopsied at 3 weeks of age, had a large and phenotypically white hair follicle clone extending dorsally from the midlateral side to the ventral area and several smaller patches, also white in phenotype, on the hindquarters, tail, and feet (Fig. 2) . The second coat-mosaic mouse C, a female still alive and derived from a clone Z cell-injected blastocyst, developed a distinct white patch on the crown of the head.
Thus far, 17 mice, including chimeric mouse A but not C, have been analyzed for internal tissue contributions from the hybrid cell implant by biochemical assays for strain-specific electrophoretic variants of GPI. Two of these experimental mice turned out to have substantial hybrid cell-derived contributions in several internal organs, ranging from 10% to 60% (Fig. 3) . The remote possibility that the tissue mosaicism might have resulted from spontaneous aggregation of experiental BL6 with control SJL blastocysts in utero was excluded by the fact that the heart, muscle, and kidney of chimeric mice A and B expressed only the BL6 (and 129) electrophoretic form of phosphoglucomutase (Pgm-1) and isocitrate dehydrogenase (Id-1) and not the SJL form. The presence of heterodimeric GPI activity in skeletal muscle attested to regular fusion of myoblasts between BL6 host and 129-type injected cell. None of the seven mosaic tissues of mouse A examined histologically in serial sections revealed any morphological abnormalities or teratoma formation. On the contrary, the subcutaneous injection of hybrid cells into athymic nude mice (20) resulted in tumors (Fig.  4) .
DISCUSSION
It has been known for some time that single embryonal carcinoma cells, the stem cell population of malignant teratocarcinomas, remain pluripotent after subcutaneous transplantation to syngeneic mice because they can give rise clonally to the FIG. 2. Coat mosaicism in chimeric mouse A, developed from a BL6 blastocyst after microinjection of a human-mouse hybrid cell. In addition to the expected black coat phenotype of the recipient, this mouse also exhibited several white patches on the back, tail, and feet and a large white clone extending from the midlateral to the ventral side, all of which derived from the injected hybrid cell and comprised about 20% of the total coat. various tissue types of these well-differentiated tumors (21) . The developmental plasticity of embryonal carcinoma cells, which resemble early embryonic cells morphologically, immunologically, and biochemically to some extent (22) , has further been revealed in the living organism by means of microinjection into mouse blastocysts (4) (5) (6) (7) (8) . For as yet unknown reasons, the transplanted stem cells of in vivo propagated teratocarcinomas derived from either a male embryo (OTT6050) or a parthenogenetically activated ovarian egg (LT 72484) lose their tumorigenic properties during the course of development and contribute normally to all major somatic tissues or, in a few instances, even differentiate into functional sperm (OTT6050) or eggs (LT72484) in chimeric mice (refs. 5 and 6; unpublished data). It had therefore been proposed earlier (23) that teratocarcinomas might provide use with a unique kind of cell which can be selected in vitro for a given somatic mutation and then cycled through mice via blastocyst injection for further in vivo analysis. Following such an experimental scheme, different sources of cultured teratocarcinoma cells that were selected either for HPRT deficiency (8) Electrophoretic analysis of strain-specific allelic variants of GPI in blood cell lysates and tissue homogenates from two chimeric mice (A and B). Control represents a 50:50 mixture of slow-migrating 129 and fast-migrating BL6 types of GPI in blood cell lysates. In each genetically mosaic mouse, clonal descendants of the injected human-mouse hybrid cell contributed substantially to several internal organs and also fused normally with myoblasts of the host, as judged from heterodimeric enzyme expression in skeletal muscle. In addition, mouse A showed conspicuous coat mosaicism (Fig. 2) whereas chimeric mouse B did not.
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